BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huttner BD, Catho G, Pano-Pardo JR, Pulcini C, Schouten J. COVID-19: don't neglect antimicrobial stewardship principles! Clin Microbiol Infect 2020;26:808-10. [PMID: 32360446 DOI: 10.1016/j.cmi.2020.04.024] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 54.0] [Reference Citation Analysis]
Number Citing Articles
1 Molla MMA, Yeasmin M, Islam MK, Sharif MM, Amin MR, Nafisa T, Ghosh AK, Parveen M, Arif MMH, Alam JAJ, Rizvi SJR, Saif-Ur-Rahman KM, Akram A, Shamsuzzaman AKM. Antibiotic Prescribing Patterns at COVID-19 Dedicated Wards in Bangladesh: Findings from a Single Center Study. Infect Prev Pract 2021;3:100134. [PMID: 34316576 DOI: 10.1016/j.infpip.2021.100134] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26:1622-9. [PMID: 32711058 DOI: 10.1016/j.cmi.2020.07.016] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 125.0] [Reference Citation Analysis]
3 Maataoui N, Chemali L, Patrier J, Tran Dinh A, Le Fèvre L, Lortat-Jacob B, Marzouk M, d'Humières C, Rondinaud E, Ruppé E, Montravers P, Timsit JF, Armand-Lefèvre L. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis 2021. [PMID: 33733394 DOI: 10.1007/s10096-021-04213-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ashiru-Oredope D, Kerr F, Hughes S, Urch J, Lanzman M, Yau T, Cockburn A, Patel R, Sheikh A, Gormley C, Chavda A, Vaghela T, Phillips C, Reid N, Brady A. Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom. Antibiotics (Basel) 2021;10:110. [PMID: 33498716 DOI: 10.3390/antibiotics10020110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
5 Nestler MJ, Godbout E, Lee K, Kim J, Noda AJ, Taylor P, Pryor R, Markley JD, Doll M, Bearman G, Stevens MP. Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center. Infect Control Hosp Epidemiol 2021;42:915-6. [PMID: 32698920 DOI: 10.1017/ice.2020.362] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
6 Usman M, Farooq M, Hanna K. Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19. Sci Total Environ 2020;745:141053. [PMID: 32702547 DOI: 10.1016/j.scitotenv.2020.141053] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 14.5] [Reference Citation Analysis]
7 Mahmoudi H. Bacterial co-infections and antibiotic resistance in patients with COVID-19. GMS Hyg Infect Control 2020;15:Doc35. [PMID: 33391970 DOI: 10.3205/dgkh000370] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Root-Bernstein R. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines (Basel) 2021;9:474. [PMID: 34066697 DOI: 10.3390/vaccines9050474] [Reference Citation Analysis]
9 Chua AQ, Verma M, Hsu LY, Legido-Quigley H. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach. Lancet Reg Health West Pac 2021;7:100084. [PMID: 34327414 DOI: 10.1016/j.lanwpc.2020.100084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Rodríguez-Baño J, Rossolini GM, Schultsz C, Tacconelli E, Murthy S, Ohmagari N, Holmes A, Bachmann T, Goossens H, Canton R, Roberts AP, Henriques-Normark B, Clancy CJ, Huttner B, Fagerstedt P, Lahiri S, Kaushic C, Hoffman SJ, Warren M, Zoubiane G, Essack S, Laxminarayan R, Plant L. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg 2021:trab048. [PMID: 33772597 DOI: 10.1093/trstmh/trab048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Suarez-de-la-Rica A, Serrano P, De-la-Oliva R, Sánchez-Díaz P, Molinero P, Falces-Romero I, Ferrando C, Rello J, Maseda E. Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter? Rev Esp Quimioter 2021;34:330-6. [PMID: 33764004 DOI: 10.37201/req/031.2021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bendala Estrada AD, Calderón Parra J, Fernández Carracedo E, Muiño Míguez A, Ramos Martínez A, Muñez Rubio E, Rubio-Rivas M, Agudo P, Arnalich Fernández F, Estrada Perez V, Taboada Martínez ML, Crestelo Vieitez A, Pesqueira Fontan PM, Bustamante M, Freire SJ, Oriol-Bermúdez I, Artero A, Olalla Sierra J, Areses Manrique M, Carrasco-Sánchez HFJ, Vento VC, García García GM, Cubero-Morais P, Casas-Rojo JM, Núñez-Cortés JM. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy. BMC Infect Dis 2021;21:1144. [PMID: 34749645 DOI: 10.1186/s12879-021-06821-1] [Reference Citation Analysis]
13 Milas S, Poncelet A, Buttafuoco F, Pardo A, Lali SE, Cherifi S. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors. Acta Clin Belg 2021;:1-9. [PMID: 33896399 DOI: 10.1080/17843286.2021.1916300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kwee TC, Kwee RM. Chest CT in COVID-19: What the Radiologist Needs to Know. Radiographics. 2020;40:1848-1865. [PMID: 33095680 DOI: 10.1148/rg.2020200159] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 29.5] [Reference Citation Analysis]
15 Khor WP, Olaoye O, D'Arcy N, Krockow EM, Elshenawy RA, Rutter V, Ashiru-Oredope D. The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations. Antibiotics (Basel) 2020;9:E904. [PMID: 33327430 DOI: 10.3390/antibiotics9120904] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 De Simone B, Chouillard E, Sartelli M, Biffl WL, Di Saverio S, Moore EE, Kluger Y, Abu-Zidan FM, Ansaloni L, Coccolini F, Leppänemi A, Peitzmann AB, Pagani L, Fraga GP, Paolillo C, Picetti E, Valentino M, Pikoulis E, Baiocchi GL, Catena F. The management of surgical patients in the emergency setting during COVID-19 pandemic: the WSES position paper. World J Emerg Surg 2021;16:14. [PMID: 33752721 DOI: 10.1186/s13017-021-00349-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Salas Orozco MF, Niño-Martínez N, Martínez-Castañón GA, Patiño Marín N, Sámano Valencia C, Dipp Velázquez FA, Sosa Munguía PDC, Casillas Santana MA. Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review. Medicina (Kaunas) 2021;57:523. [PMID: 34070998 DOI: 10.3390/medicina57060523] [Reference Citation Analysis]
18 Umakanthan S, Chattu VK, Ranade AV, Das D, Basavarajegowda A, Bukelo M. A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19. AIMS Public Health 2021;8:137-53. [PMID: 33575413 DOI: 10.3934/publichealth.2021011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
19 O'Riordan F, Shiely F, Byrne S, O'Brien D, Ronayne A, Fleming A. Antimicrobial use and antimicrobial resistance in Enterobacterales and Enterococcus faecium: a time series analysis. J Hosp Infect 2021:S0195-6701(21)00390-X. [PMID: 34780809 DOI: 10.1016/j.jhin.2021.11.003] [Reference Citation Analysis]
20 Yu CY, Chan KG, Yean CY, Ang GY. Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update. Diagnostics (Basel) 2021;11:53. [PMID: 33401392 DOI: 10.3390/diagnostics11010053] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
21 Panneer S, Kantamaneni K, Pushparaj RRB, Shekhar S, Bhat L, Rice L. Multistakeholder Participation in Disaster Management-The Case of the COVID-19 Pandemic. Healthcare (Basel) 2021;9:203. [PMID: 33668669 DOI: 10.3390/healthcare9020203] [Reference Citation Analysis]
22 Akhtar Z, Mah-E-Muneer S, Rashid MM, Ahmed MS, Islam MA, Chowdhury S, Khan Z, Hassan MZ, Islam K, Parveen S, Debnath N, Rahman M, Chowdhury F. Antibiotics Use and Its Knowledge in the Community: A Mobile Phone Survey during the COVID-19 Pandemic in Bangladesh. Antibiotics (Basel) 2021;10:1052. [PMID: 34572634 DOI: 10.3390/antibiotics10091052] [Reference Citation Analysis]
23 Evans TJ, Davidson HC, Low JM, Basarab M, Arnold A. Antibiotic usage and stewardship in patients with COVID-19: too much antibiotic in uncharted waters? J Infect Prev 2021;22:119-25. [PMID: 34239610 DOI: 10.1177/1757177420976813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Colliers A, De Man J, Adriaenssens N, Verhoeven V, Anthierens S, De Loof H, Philips H, Coenen S, Morreel S. Antibiotic Prescribing Trends in Belgian Out-of-Hours Primary Care during the COVID-19 Pandemic: Observational Study Using Routinely Collected Health Data. Antibiotics (Basel) 2021;10:1488. [PMID: 34943701 DOI: 10.3390/antibiotics10121488] [Reference Citation Analysis]
25 Rangel K, Chagas TPG, De-Simone SG. Acinetobacter baumannii Infections in Times of COVID-19 Pandemic. Pathogens 2021;10:1006. [PMID: 34451470 DOI: 10.3390/pathogens10081006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Spigaglia P. COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients. Anaerobe 2020;64:102233. [PMID: 32593567 DOI: 10.1016/j.anaerobe.2020.102233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
27 Hazel K, Skally M, Glynn E, Foley M, Burns K, O'Toole A, Boland K, Fitzpatrick F. The other 'C': Hospital-acquired Clostridioides difficile infection during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2021;:1-2. [PMID: 33436112 DOI: 10.1017/ice.2021.3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Preetam M, Anurag A. MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort. J Family Med Prim Care 2021;10:223-7. [PMID: 34017730 DOI: 10.4103/jfmpc.jfmpc_1766_20] [Reference Citation Analysis]
29 Mah-E-Muneer S, Hassan MZ, Biswas MAAJ, Rahman F, Akhtar Z, Das P, Islam MA, Chowdhury F. Use of Antimicrobials among Suspected COVID-19 Patients at Selected Hospitals, Bangladesh: Findings from the First Wave of COVID-19 Pandemic. Antibiotics (Basel) 2021;10:738. [PMID: 34207020 DOI: 10.3390/antibiotics10060738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Staub MB, Beaulieu RM, Graves J, Nelson GE. Changes in antimicrobial utilization during the coronavirus disease 2019 (COVID-19) pandemic after implementation of a multispecialty clinical guidance team. Infect Control Hosp Epidemiol 2021;42:810-6. [PMID: 33100250 DOI: 10.1017/ice.2020.1291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Guisado-Gil AB, Infante-Domínguez C, Peñalva G, Praena J, Roca C, Navarro-Amuedo MD, Aguilar-Guisado M, Espinosa-Aguilera N, Poyato-Borrego M, Romero-Rodríguez N, Aldabó T, Salto-Alejandre S, Ruiz-Pérez de Pipaón M, Lepe JA, Martín-Gutiérrez G, Gil-Navarro MV, Molina J, Pachón J, Cisneros JM, On Behalf Of The Prioam Team. Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections. Antibiotics (Basel) 2020;9:E816. [PMID: 33212785 DOI: 10.3390/antibiotics9110816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
32 Liu HH, Yaron D, Piraino AS, Kapelusznik L. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. Ann Clin Microbiol Antimicrob 2021;20:69. [PMID: 34563202 DOI: 10.1186/s12941-021-00472-5] [Reference Citation Analysis]
33 Andrews A, Budd EL, Hendrick A, Ashiru-Oredope D, Beech E, Hopkins S, Gerver S, Muller-Pebody B, The Amu Covid-Stakeholder Group. Surveillance of Antibacterial Usage during the COVID-19 Pandemic in England, 2020. Antibiotics (Basel) 2021;10:841. [PMID: 34356762 DOI: 10.3390/antibiotics10070841] [Reference Citation Analysis]
34 Martinez-Guerra BA, Gonzalez-Lara MF, de-Leon-Cividanes NA, Tamez-Torres KM, Roman-Montes CM, Rajme-Lopez S, Villalobos-Zapata GI, Lopez-Garcia NI, Martínez-Gamboa A, Sifuentes-Osornio J, Ortiz-Brizuela E, Ochoa-Hein E, Galindo-Fraga A, Bobadilla-Del-Valle M, Ponce-de-León A. Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic. Antibiotics (Basel) 2021;10:182. [PMID: 33670316 DOI: 10.3390/antibiotics10020182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
35 Abelenda-Alonso G, Padullés A, Rombauts A, Gudiol C, Pujol M, Alvarez-Pouso C, Jodar R, Carratalà J. Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern. Infect Control Hosp Epidemiol 2020;41:1371-2. [PMID: 32729437 DOI: 10.1017/ice.2020.381] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
36 Para O, Caruso L, Ronchetti M, Finocchi M, Guidi S, Spinicci M. Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship. Intern Emerg Med 2021;16:789-91. [PMID: 33222117 DOI: 10.1007/s11739-020-02537-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Azimirad M, Noori M, Raeisi H, Yadegar A, Shahrokh S, Asadzadeh Aghdaei H, Bentivegna E, Martelletti P, Petrosillo N, Zali MR. How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? Front Med (Lausanne) 2021;8:775063. [PMID: 34966759 DOI: 10.3389/fmed.2021.775063] [Reference Citation Analysis]
38 Van Laethem J, Wuyts S, Van Laere S, Dirkx S, Seyler L, Mertens R, Ilsen B, Lacor P, Pierard D, Allard SD. Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study. Infect Dis Ther 2021;10:2575-91. [PMID: 34529255 DOI: 10.1007/s40121-021-00535-2] [Reference Citation Analysis]
39 Shin DH, Kang M, Song KH, Jung J, Kim ES, Kim HB. A call for antimicrobial stewardship in patients with COVID-19: a nationwide cohort study in Korea. Clin Microbiol Infect 2021;27:653-5. [PMID: 33137513 DOI: 10.1016/j.cmi.2020.10.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Sharma B, Sreenivasan P, Biswal M, Mahajan V, Suri V, Singh Sehgal I, Ray P, Dutt Puri G, Bhalla A, Narayana Yaddanapudi L, Koushal V, Angrup A. Bacterial coinfections and secondary infections in COVID-19 patients from a tertiary care hospital of northern India: Time to adhere to culture-based practices. Qatar Med J 2021;2021:62. [PMID: 34745914 DOI: 10.5339/qmj.2021.62] [Reference Citation Analysis]
41 van Berkel M, Kox M, Frenzel T, Pickkers P, Schouten J; RCI-COVID-19 study group. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? Crit Care 2020;24:600. [PMID: 33023606 DOI: 10.1186/s13054-020-03291-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
42 Bork JT, Leekha S, Claeys K, Seung H, Tripoli M, Amoroso A, Heil EL. Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019. Infect Control Hosp Epidemiol 2020;:1-3. [PMID: 33298211 DOI: 10.1017/ice.2020.1360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
43 Granata G, Bartoloni A, Codeluppi M, Contadini I, Cristini F, Fantoni M, Ferraresi A, Fornabaio C, Grasselli S, Lagi F, Masucci L, Puoti M, Raimondi A, Taddei E, Trapani FF, Viale P, Johnson S, Petrosillo N, On Behalf Of The CloVid Study Group. The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid). J Clin Med 2020;9:E3855. [PMID: 33260943 DOI: 10.3390/jcm9123855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
44 Bhargava K, Nath G, Bhargava A, Aseri GK, Jain N. Phage therapeutics: from promises to practices and prospectives. Appl Microbiol Biotechnol 2021;105:9047-67. [PMID: 34821965 DOI: 10.1007/s00253-021-11695-z] [Reference Citation Analysis]
45 Peters C, Williams K, Un EA, Little L, Saad A, Lendrum K, Thompson N, Weatherley ND, Pegden A. Use of procalcitonin for antibiotic stewardship in patients with COVID-19: A quality improvement project in a district general hospital. Clin Med (Lond) 2021;21:e71-6. [PMID: 33355197 DOI: 10.7861/clinmed.2020-0614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
46 Rose AN, Baggs J, Wolford H, Neuhauser MM, Srinivasan A, Gundlapalli AV, Reddy S, Kompaniyets L, Pennington AF, Grigg C, Kabbani S. Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic. Open Forum Infect Dis 2021;8:ofab236. [PMID: 34226869 DOI: 10.1093/ofid/ofab236] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Last K, Power NR, Dellière S, Velikov P, Šterbenc A, Antunovic IA, Lopes MJ, Schweitzer V, Barac A; Trainee Association of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Future developments in training. Clin Microbiol Infect 2021:S1198-743X(21)00363-3. [PMID: 34197928 DOI: 10.1016/j.cmi.2021.06.032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Beović B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, Berger-Estilita J, Ayoade F, Rello J, Erdem H. Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother 2020;75:3386-90. [PMID: 32766706 DOI: 10.1093/jac/dkaa326] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 26.5] [Reference Citation Analysis]
49 Sulis G, Daniels B, Kwan A, Gandra S, Daftary A, Das J, Pai M. Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya. BMJ Glob Health 2020;5:e003393. [PMID: 32938614 DOI: 10.1136/bmjgh-2020-003393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
50 d'Humières C, Patrier J, Lortat-Jacob B, Tran-Dinh A, Chemali L, Maataoui N, Rondinaud E, Ruppé E, Burdet C, Ruckly S, Montravers P, Timsit JF, Armand-Lefevre L. Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France. PLoS One 2021;16:e0250728. [PMID: 33914786 DOI: 10.1371/journal.pone.0250728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Kumar S, Mehta S, Sarangdhar N, Ray A, Sinha S, Wig N. Management of COVID-19 from the pulmonologist's perspective: a narrative review. Expert Rev Respir Med 2021;15:519-35. [PMID: 33211553 DOI: 10.1080/17476348.2021.1853529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Luo Y, Tang X, Ding L, Shao Z, Yu J, Chen Y, Zhou Y, He H, Chen Z. Non-prescriptionxx antibiotic use for people aged 15 years or older for cough in China: a community-based survey. Antimicrob Resist Infect Control 2021;10:129. [PMID: 34461998 DOI: 10.1186/s13756-021-00998-5] [Reference Citation Analysis]
53 Gagliotti C, Buttazzi R, Ricchizzi E, Di Mario S, Tedeschi S, Moro ML. Community use of antibiotics during the COVID-19 lockdown. Infect Dis (Lond) 2021;53:142-4. [PMID: 33073645 DOI: 10.1080/23744235.2020.1834139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
54 Adebisi YA, Alaran AJ, Okereke M, Oke GI, Amos OA, Olaoye OC, Oladunjoye I, Olanrewaju AY, Ukor NA, Lucero-Prisno DE 3rd. COVID-19 and Antimicrobial Resistance: A Review. Infect Dis (Auckl) 2021;14:11786337211033870. [PMID: 34376994 DOI: 10.1177/11786337211033870] [Reference Citation Analysis]
55 Rezasoltani S, Yadegar A, Hatami B, Asadzadeh Aghdaei H, Zali MR. Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR. Front Microbiol 2020;11:590683. [PMID: 33384670 DOI: 10.3389/fmicb.2020.590683] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
56 Keating JA, McKinley L, Safdar N. Coronavirus disease 2019 (COVID-19) and antibiotic stewardship: Using a systems engineering approach to maintain patient safety. Infect Control Hosp Epidemiol 2021;42:1416-8. [PMID: 33040756 DOI: 10.1017/ice.2020.1263] [Reference Citation Analysis]
57 Eid RA, Elgendy MO, El-Gendy AO, Elgendy SO, Belbahri L, Sayed AM, Rateb ME. Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt. Antibiotics (Basel) 2021;10:1278. [PMID: 34827216 DOI: 10.3390/antibiotics10111278] [Reference Citation Analysis]
58 Cona A, Tavelli A, Renzelli A, Varisco B, Bai F, Tesoro D, Za A, Biassoni C, Battaglioli L, Allegrini M, Viganò O, Gazzola L, Bini T, Marchetti GC, d'Arminio Monforte A. Incidence, Risk Factors and Impact on Clinical Outcomes of Bloodstream Infections in Patients Hospitalised with COVID-19: A Prospective Cohort Study. Antibiotics (Basel) 2021;10:1031. [PMID: 34572613 DOI: 10.3390/antibiotics10091031] [Reference Citation Analysis]
59 Pascale R, Bussini L, Gaibani P, Bovo F, Fornaro G, Lombardo D, Ambretti S, Pensalfine G, Appolloni L, Bartoletti M, Tedeschi S, Tumietto F, Lewis R, Viale P, Giannella M. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. Infect Control Hosp Epidemiol 2021;:1-6. [PMID: 33858547 DOI: 10.1017/ice.2021.144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
60 Kim H, Lee S, Seo HW, Kang B, Moon J, Lee KG, Yong D, Kang H, Jung J, Lim EK, Jeong J, Park HG, Ryu CM, Kang T. Clustered Regularly Interspaced Short Palindromic Repeats-Mediated Surface-Enhanced Raman Scattering Assay for Multidrug-Resistant Bacteria. ACS Nano 2020. [PMID: 33216524 DOI: 10.1021/acsnano.0c07264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
61 Pelfrene E, Botgros R, Cavaleri M. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight? Antimicrob Resist Infect Control 2021;10:21. [PMID: 33514424 DOI: 10.1186/s13756-021-00893-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
62 Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect 2021;27:9-11. [PMID: 32979569 DOI: 10.1016/j.cmi.2020.09.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
63 Granata G, Petrosillo N, Al Moghazi S, Caraffa E, Puro V, Tillotson G, Cataldo MA. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis. Anaerobe 2021;:102484. [PMID: 34843959 DOI: 10.1016/j.anaerobe.2021.102484] [Reference Citation Analysis]
64 . Antimicrobial resistance in the age of COVID-19. Nat Microbiol 2020;5:779-779. [DOI: 10.1038/s41564-020-0739-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
65 Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, Muccini C, Monti G, De Luca G, Landoni G, Dagna L, Clementi M, Rovere Querini P, Ciceri F, Tresoldi M, Lazzarin A, Zangrillo A, Scarpellini P, Castagna A; COVID-BioB study group. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect 2021;27:451-7. [PMID: 33223114 DOI: 10.1016/j.cmi.2020.10.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 21.5] [Reference Citation Analysis]
66 Crisan-Dabija R, Pavel CA, Popa IV, Tarus A, Burlacu A. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19. J Proteome Res 2020;19:4327-38. [PMID: 32883081 DOI: 10.1021/acs.jproteome.0c00387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
67 Cantón R, Gijón D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr Opin Crit Care 2020;26:433-41. [PMID: 32739970 DOI: 10.1097/MCC.0000000000000755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
68 Batiha GE, Zayed MA, Awad AA, Shaheen HM, Mustapha S, Herrera-Calderon O, Pagnossa JP, Algammal AM, Zahoor M, Adhikari A, Pandey I, Elazab ST, Rengasamy KRR, Cruz-Martins N, Hetta HF. Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19. Front Med (Lausanne) 2021;8:642313. [PMID: 33937285 DOI: 10.3389/fmed.2021.642313] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Jolobe OMP. A more appropriate use of antibiotics in covid-19 infection. QJM 2021:hcab233. [PMID: 34487187 DOI: 10.1093/qjmed/hcab233] [Reference Citation Analysis]
70 Arcari G, Raponi G, Sacco F, Bibbolino G, Di Lella FM, Alessandri F, Coletti M, Trancassini M, Deales A, Pugliese F, Antonelli G, Carattoli A. Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital. Int J Antimicrob Agents 2021;57:106245. [PMID: 33253903 DOI: 10.1016/j.ijantimicag.2020.106245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
71 Mody L, Akinboyo IC, Babcock HM, Bischoff WE, Cheng VC, Chiotos K, Claeys KC, Coffey KC, Diekema DJ, Donskey CJ, Ellingson KD, Gilmartin HM, Gohil SK, Harris AD, Keller SC, Klein EY, Krein SL, Kwon JH, Lauring AS, Livorsi DJ, Lofgren ET, Merrill K, Milstone AM, Monsees EA, Morgan DJ, Perri LP, Pfeiffer CD, Rock C, Saint S, Sickbert-Bennett E, Skelton F, Suda KJ, Talbot TR, Vaughn VM, Weber DJ, Wiemken TL, Yassin MH, Ziegler MJ, Anderson DJ; SHEA Research Committee. Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology. Infect Control Hosp Epidemiol 2021;:1-11. [PMID: 33487199 DOI: 10.1017/ice.2021.25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Stefanini I, De Renzi G, Foddai E, Cordani E, Mognetti B. Profile of Bacterial Infections in COVID-19 Patients: Antimicrobial Resistance in the Time of SARS-CoV-2. Biology (Basel) 2021;10:822. [PMID: 34571699 DOI: 10.3390/biology10090822] [Reference Citation Analysis]
73 Schons MJ, Caliebe A, Spinner CD, Classen AY, Pilgram L, Ruethrich MM, Rupp J, Nunes de Miranda S, Römmele C, Vehreschild J, Jensen BE, Vehreschild M, Degenhardt C, Borgmann S, Hower M, Hanses F, Haselberger M, Friedrichs AK; LEOSS-study group. All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort. Infection 2021. [PMID: 34625912 DOI: 10.1007/s15010-021-01699-2] [Reference Citation Analysis]
74 Hoque MN, Akter S, Mishu ID, Islam MR, Rahman MS, Akhter M, Islam I, Hasan MM, Rahaman MM, Sultana M, Islam T, Hossain MA. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis. Microb Pathog 2021;156:104941. [PMID: 33962007 DOI: 10.1016/j.micpath.2021.104941] [Reference Citation Analysis]
75 Youngs J, Wyncoll D, Hopkins P, Arnold A, Ball J, Bicanic T. Improving antibiotic stewardship in COVID-19: Bacterial co-infection is less common than with influenza. J Infect 2020;81:e55-7. [PMID: 32593654 DOI: 10.1016/j.jinf.2020.06.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
76 Putot A, Bouiller K, Laborde C, Gilis M, Févre A, Hacquin A, Manckoundia P, Hoefler F, Bermejo M, Mendes A, Serratrice C, Prendki V, Sanchez S. Association between Early Antibiotic Therapy and In-Hospital Mortality among Older Patients with SARS-CoV-2 Pneumonia. J Gerontol A Biol Sci Med Sci 2021:glab209. [PMID: 34272847 DOI: 10.1093/gerona/glab209] [Reference Citation Analysis]
77 Cong W, Poudel AN, Alhusein N, Wang H, Yao G, Lambert H. Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review. Antibiotics (Basel) 2021;10:745. [PMID: 34205440 DOI: 10.3390/antibiotics10060745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Castro-Lopes A, Correia S, Leal C, Resende I, Soares P, Azevedo A, Paiva JA. Increase of Antimicrobial Consumption in a Tertiary Care Hospital during the First Phase of the COVID-19 Pandemic. Antibiotics (Basel) 2021;10:778. [PMID: 34202340 DOI: 10.3390/antibiotics10070778] [Reference Citation Analysis]
79 Buetti N, Mazzuchelli T, Lo Priore E, Balmelli C, Llamas M, Pallanza M, Elzi L, Consonni V, Trimboli P, Forni-Ogna V, Bernasconi E. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19. J Infect 2020;81:e148-9. [PMID: 32512022 DOI: 10.1016/j.jinf.2020.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
80 Cheng LS, Chau SK, Tso EY, Tsang SW, Li IY, Wong BK, Fung KS. Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster. Ther Adv Infect Dis 2020;7:2049936120978095. [PMID: 33335724 DOI: 10.1177/2049936120978095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
81 Nebreda-Mayoral T, Miguel-Gómez MA, March-Rosselló GA, Puente-Fuertes L, Cantón-Benito E, Martínez-García AM, Muñoz-Martín AB, Orduña-Domingo A. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain. Enferm Infecc Microbiol Clin (Engl Ed) 2020:S0213-005X(20)30404-3. [PMID: 33413990 DOI: 10.1016/j.eimc.2020.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
82 Abelenda-Alonso G, Rombauts A, Gudiol C, Oriol I, Simonetti A, Coloma A, Rodríguez-Molinero A, Izquierdo E, Díaz-Brito V, Sanmartí M, Padullés A, Grau I, Ras M, Bergas A, Guillem L, Blanco-Arévalo A, Alvarez-Pouso C, Pallarés N, Videla S, Tebé C, Carratalà J. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicentre study (BACTCOVID). Clin Microbiol Infect 2021:S1198-743X(21)00372-4. [PMID: 34242804 DOI: 10.1016/j.cmi.2021.06.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Sheikh AAE, Sheikh AB, Shah I, Khair AH, Javed N, Shekhar R. COVID-19 and Fulminant Clostridium difficile Colitis Co-Infection. Eur J Case Rep Intern Med 2021;8:002771. [PMID: 34527627 DOI: 10.12890/2021_002771] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Gouin KA, Creasy S, Beckerson M, Wdowicki M, Hicks LA, Lind JN, Geller AI, Budnitz DS, Kabbani S. Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic. Clin Infect Dis 2021:ciab225. [PMID: 33693607 DOI: 10.1093/cid/ciab225] [Reference Citation Analysis]
85 Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, Daneman N, MacFadden DR. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 2021;27:520-31. [PMID: 33418017 DOI: 10.1016/j.cmi.2020.12.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 42.0] [Reference Citation Analysis]
86 Mayi BS, Mainville M, Altaf R, Lanspa M, Vaniawala S, Ollerhead TA, Raja A. A Crucial Role for Antimicrobial Stewardship in the Midst of COVID-19. J Microbiol Biol Educ 2021;22. [DOI: 10.1128/jmbe.v22i1.2285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Ansari S, Hays JP, Kemp A, Okechukwu R, Murugaiyan J, Ekwanzala MD, Ruiz Alvarez MJ, Paul-Satyaseela M, Iwu CD, Balleste-Delpierre C, Septimus E, Mugisha L, Fadare J, Chaudhuri S, Chibabhai V, Wadanamby JMRWW, Daoud Z, Xiao Y, Parkunan T, Khalaf Y, M'Ikanatha NM, van Dongen MBM; Global AMR Insights Ambassador Network . The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective. JAC Antimicrob Resist 2021;3:dlab038. [PMID: 34192258 DOI: 10.1093/jacamr/dlab038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, Hu T, Li J, Zhou X, Ren B. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol 2020;104:7777-85. [PMID: 32780290 DOI: 10.1007/s00253-020-10814-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 25.0] [Reference Citation Analysis]
89 Colaneri M, Valsecchi P, Vecchia M, Di Filippo A, Zuccaro V, Seminari E, Sacchi P, Maiocchi L, Fabbiani M, Ricciardi A, Muzzi A, Bruno R. What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web survey helps us to understand where the doubts lie. J Glob Antimicrob Resist 2021;26:74-6. [PMID: 34118478 DOI: 10.1016/j.jgar.2021.05.014] [Reference Citation Analysis]
90 Sulis G, Sayood S, Gandra S. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Expert Rev Anti Infect Ther 2021;:1-14. [PMID: 34225545 DOI: 10.1080/14787210.2021.1951705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Hannawi S, Hannawi H, Naeem KB, Elemam NM, Hachim MY, Hachim IY, Darwish AS, Al Salmi I. Clinical and Laboratory Profile of Hospitalized Symptomatic COVID-19 Patients: Case Series Study From the First COVID-19 Center in the UAE. Front Cell Infect Microbiol 2021;11:632965. [PMID: 33718282 DOI: 10.3389/fcimb.2021.632965] [Reference Citation Analysis]
92 Miethke M, Pieroni M, Weber T, Brönstrup M, Hammann P, Halby L, Arimondo PB, Glaser P, Aigle B, Bode HB, Moreira R, Li Y, Luzhetskyy A, Medema MH, Pernodet JL, Stadler M, Tormo JR, Genilloud O, Truman AW, Weissman KJ, Takano E, Sabatini S, Stegmann E, Brötz-Oesterhelt H, Wohlleben W, Seemann M, Empting M, Hirsch AKH, Loretz B, Lehr CM, Titz A, Herrmann J, Jaeger T, Alt S, Hesterkamp T, Winterhalter M, Schiefer A, Pfarr K, Hoerauf A, Graz H, Graz M, Lindvall M, Ramurthy S, Karlén A, van Dongen M, Petkovic H, Keller A, Peyrane F, Donadio S, Fraisse L, Piddock LJV, Gilbert IH, Moser HE, Müller R. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem 2021;:1-24. [PMID: 34426795 DOI: 10.1038/s41570-021-00313-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Tiseo G, Yahav D, Paul M, Tinelli M, Gavazzi G, Mussini C, Prendki V, Falcone M. What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group. Eur J Clin Microbiol Infect Dis 2021. [PMID: 34775534 DOI: 10.1007/s10096-021-04377-1] [Reference Citation Analysis]
94 Mahalmani V, Kumaravel J, Jain M, Prakash A, Medhi B. Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak. Indian J Pharmacol 2021;53:187-91. [PMID: 34169902 DOI: 10.4103/ijp.ijp_430_21] [Reference Citation Analysis]
95 Saha M, Sarkar A. Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century. J Xenobiot 2021;11:197-214. [PMID: 34940513 DOI: 10.3390/jox11040013] [Reference Citation Analysis]
96 Avershina E, Shapovalova V, Shipulin G. Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy. Front Microbiol 2021;12:707330. [PMID: 34367112 DOI: 10.3389/fmicb.2021.707330] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
97 Scott H, Zahra A, Fernandes R, Fries BC, Thode HC Jr, Singer AJ. Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia. Am J Emerg Med 2022;51:1-5. [PMID: 34637995 DOI: 10.1016/j.ajem.2021.09.040] [Reference Citation Analysis]
98 Kalam A, Shano S, Khan MA, Islam A, Warren N, Hassan MM, Davis M. Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance. PLoS One 2021;16:e0261368. [PMID: 34905563 DOI: 10.1371/journal.pone.0261368] [Reference Citation Analysis]
99 Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Paño-Pardo JR, Power NR, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Zollner-Schwetz I, Rodríguez-Baño J. ESCMID COVID-19 Living guidelines: drug treatment and clinical management. Clin Microbiol Infect 2021:S1198-743X(21)00634-0. [PMID: 34823008 DOI: 10.1016/j.cmi.2021.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Razzaque MS. Exacerbation of antimicrobial resistance: another casualty of the COVID-19 pandemic? Expert Rev Anti Infect Ther 2021;19:967-71. [PMID: 33322965 DOI: 10.1080/14787210.2021.1865802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
101 O'Kelly B, Rueda-Benito A, O'Regan M, Finan K. An audit of community-acquired pneumonia antimicrobial compliance using an intervention bundle in an Irish hospital. J Glob Antimicrob Resist 2020;23:38-45. [PMID: 32801028 DOI: 10.1016/j.jgar.2020.07.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, Cally R, Logre E, Fraissé M, Mentec H, Plantefève G. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care 2020;10:119. [PMID: 32894364 DOI: 10.1186/s13613-020-00736-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 32.5] [Reference Citation Analysis]
103 Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World J Clin Cases 2021; 9(33): 10180-10188 [PMID: 34904088 DOI: 10.12998/wjcc.v9.i33.10180] [Reference Citation Analysis]
104 Drewett GP, Smibert OC, Holmes NE, Trubiano JA. The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol 2021;:1-3. [PMID: 33487208 DOI: 10.1017/ice.2021.28] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 van Duin D, Barlow G, Nathwani D. The impact of the COVID-19 pandemic on antimicrobial resistance: a debate. JAC Antimicrob Resist 2020;2:dlaa053. [PMID: 34192250 DOI: 10.1093/jacamr/dlaa053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
106 Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53:505-512. [PMID: 32482366 DOI: 10.1016/j.jmii.2020.05.013] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 60.0] [Reference Citation Analysis]
107 Calderón-Parra J, Muiño-Miguez A, Bendala-Estrada AD, Ramos-Martínez A, Muñez-Rubio E, Fernández Carracedo E, Tejada Montes J, Rubio-Rivas M, Arnalich-Fernandez F, Beato Pérez JL, García Bruñén JM, Del Corral Beamonte E, Pesqueira Fontan PM, Carmona MDM, Fernández-Madera Martínez R, González García A, Salazar Mosteiro C, Tuñón de Almeida C, González Moraleja J, Deodati F, Martín Escalante MD, Asensio Tomás ML, Gómez Huelgas R, Casas Rojo JM, Millán Núñez-Cortés J; SEMI-COVID-19 Network. Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One 2021;16:e0251340. [PMID: 33974637 DOI: 10.1371/journal.pone.0251340] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
108 Velasco-Arnaiz E, López-Ramos MG, Simó-Nebot S, Jordan I, Ríos-Barnés M, Urrea-Ayala M, Monsonís M, Fortuny C, Noguera-Julian A; Kids Corona project. Pediatric antimicrobial stewardship in the COVID-19 outbreak. Infect Control Hosp Epidemiol 2021;42:642-4. [PMID: 32576298 DOI: 10.1017/ice.2020.312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
109 Van Laethem J, Wuyts S, Van Laere S, Koulalis J, Colman M, Moretti M, Seyler L, De Waele E, Pierard D, Lacor P, Allard SD. Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers. Intern Emerg Med 2021. [PMID: 34185257 DOI: 10.1007/s11739-021-02790-0] [Reference Citation Analysis]
110 Karami Z, Knoop BT, Dofferhoff ASM, Blaauw MJT, Janssen NA, van Apeldoorn M, Kerckhoffs APM, van de Maat JS, Hoogerwerf JJ, Ten Oever J. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis (Lond) 2021;53:102-10. [PMID: 33103530 DOI: 10.1080/23744235.2020.1839672] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
111 Ghosh S, Bornman C, Zafer MM. Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand? J Infect Public Health 2021;14:555-60. [PMID: 33848884 DOI: 10.1016/j.jiph.2021.02.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
112 Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, Petrosillo N, Mastroianni C, Cascio A, Iaria C, Galli M, Chirianni A, Sagnelli E, Iacobello C, Di Perri G, Mazzotta F, Carosi G, Tinelli M, Grossi P, Armignacco O, Portelli V, Andreoni M, Tavio M; Italian Society of Infectious and Tropical Diseases. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT). Clin Microbiol Infect 2021;27:389-95. [PMID: 33359375 DOI: 10.1016/j.cmi.2020.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
113 Peñalva G, Benavente RS, Pérez-Moreno MA, Pérez-Pacheco MD, Pérez-Milena A, Murcia J, Cisneros JM. Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care. Clin Microbiol Infect 2021;27:1058-60. [PMID: 33540117 DOI: 10.1016/j.cmi.2021.01.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
114 Liew Y, Lee WHL, Tan L, Kwa ALH, Thien SY, Cherng BPZ, Chung SJ. Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19). Int J Antimicrob Agents 2020;56:106145. [PMID: 32860880 DOI: 10.1016/j.ijantimicag.2020.106145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
115 Yock-Corrales A, Lenzi J, Ulloa-Gutiérrez R, Gómez-Vargas J, Antúnez-Montes OY, Rios Aida JA, Del Aguila O, Arteaga-Menchaca E, Campos F, Uribe F, Parra Buitrago A, Maria Betancur Londoño L, Brizuela M, Buonsenso D. High rates of antibiotic prescriptions in children with COVID-19 or multisystem inflammatory syndrome: A multinational experience in 990 cases from Latin America. Acta Paediatr 2021;110:1902-10. [PMID: 33742466 DOI: 10.1111/apa.15847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]